Schedule 13G ownership disclosure

ENTEROMEDICS INC

Security class unavailable · CUSIP: 29365M505

Event date: 2017-12-19

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
14.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-17-382679
Form type
SC 13G
Filer
ReShape Lifesciences Inc.
CIK
CIK 1371217
Filed
Dec 29, 2017
Reporting period
Dec 19, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub